TPO and hematocrit: In 26.9% of PCOS patients and 8.3% of the control group, HT-specific anti-TPO or anti-thyroglobulin (TG) antibody levels were found to be elevated, revealing a threefold increase in the prevalence of HT in PCOS patients relative to controls.